Citation:

Kenyon, E., C. Eklund, R. Pegram, AND J. Lipscomb. Comparison of In Vivo Derived and Scaled In Vitro Metabolic Rate Constants for Several Volatile Organic Compounds (VOCs). TOXICOLOGY IN VITRO. Elsevier Science Ltd, New York, NY, 69:105002, (2020). https://doi.org/10.1016/j.tiv.2020.105002

Impact/Purpose:

Estimating human metabolism of environmental chemicals using in vitro data is necessary due to the numbers of chemicals for which data are needed, trends towards minimizing laboratory animal use, and very limited opportunity to collect data in human subjects. We evaluated how well and to what extent metabolic rate parameters derived from in vitro data predict overall in vivo metabolism for a set of environmental chemicals for which well validated and established methods to estimate in vivo metabolic clearance exist. For 6 of 7 volatile organic chemicals, differences between the in vivo and scaled up in vitro metabolism estimates were less than 2.6-fold. Systematic and reliable utilization of scaled up in vitro biotransformation rate parameters in PBPK models will require development of methods to predict cases in which extrahepatic metabolism and binding as well as other factors are likely to be significant contributors.

Description:

Metabolic rate parameters estimation using in vitro data is necessary due to numbers of chemicals for which data are needed, trend towards minimizing laboratory animal use, and limited opportunity to collect data in human subjects. We evaluated how well metabolic rate parameters derived from in vitro data predict overall in vivo metabolism for a set of environmental chemicals for which well validated and established methods exist. We compared values of VmaxC derived from in vivo vapor uptake studies with estimates of VmaxC scaled up from in vitro hepatic microsomal metabolism studies for VOCs for which data were available in male F344 rats. For 6 of 7 VOCs, differences between the in vivo and scaled up in vitro VmaxC estimates were less than 2.6-fold. For bromodichloromethane (BDCM), the in vivo derived VmaxC was approximately 4.4-fold higher than the in vitro derived and scaled up VmaxC. The more rapid rate of BDCM metabolism estimated based in vivo studies suggests other factors such as extrahepatic metabolism, binding or other non-specific losses making a significant contribution to overall clearance. Systematic and reliable utilization of scaled up in vitro biotransformation rate parameters in PBPK models will require development of methods to predict cases in which extrahepatic metabolism and binding as well as other factors are likely to be significant contributors.

URLs/Downloads:

Record Details: